(Prison-Based Harm Reduction) "For the purpose of preventing against drug-related diseases, physical withdrawal symptoms, and mental craving for drugs, the Danish Prison and Probation Service provides medical substitution treatment. This temporary treatment may extend over weeks or months. It is very to a wide extent followed by continuous substitution treatment that may last up to several years when deemed necessary by an interdisciplinary panel of people –which is more the rule than the exception.
(Drug Use and Social Exclusion) "In Denmark, there is a clear correlation between drug abuse and problematic social and economic life conditions. The social marginalization of drug abusers is high. When taking a look at the social, residential and educational conditions among the drug abusers in treatment, it is clear that they are a marginalized group compared to the rest of the population. They are more often homeless, they more often have a short educational background and they are more frequently provided for through cash benefits and pensions.
(Estimated Prevalence of Injection Drug Use in Denmark) "During the period 2004-2008, the then National Board of Health supported the DEADHEP project, under which, as part of the study on HIV and hepatitis prevalence among drug-related deaths in Denmark, also by means of autopsies, it was examined whether or not the deceased suffered from hepatitis as a sign of intravenous drug abuse (Christensen et al 2006) (read more in chapter 6).
(Syringe Exchange Availability in Denmark) "In 2009, as a result of a request from the Ministry of Health, Local Government Denmark looked into the prevalence of syringe exchange schemes in the various municipalities in Denmark. In its report, Local Government Denmark concluded that the number of drug abusers who have access to clean syringes and needles is high. The reason is that all the large municipalities that have a relatively large number of drug abusers hand-out clean "tools".
(1995 & 1999 - Denmark - youth cannabis use) "In 1995, more than 17% of the 15-16 year-olds report ever having tried cannabis. There was a significant increase in 1999 where the share that state having ever tried cannabis is over 24%. 8% had used it within the last month; in 1995 this was 6%. There are great differences in experimental use between boys and girls in 1999 when 30% of boys and 19% of girls state having ever used cannabis. Twice as many boys as girls had used cannabis during the last month."
(Prevalence of Problem Drug Use in Denmark) "The estimate on the number of drug abusers is associated with some uncertainty. The estimate is dependent, in one respect, on the definition of a drug abuser, and in another, on which methods and data material the estimate is based.
(Prevalence of Cannabis Use in Denmark) "Results from the population surveys among the 16-44-year-olds made in 1994, 2000, 2005, 2008, and 2010 show increases in the experimental use of cannabis up until 2000, and from then on remain on a fairly stable level up until 2010, cf. table 2.2.1. Among both men and women, the current use of cannabis is highest among the young population (16 – 24 years) and then tapers off by increasing age (cf. table 2.2.2 of the annex).
(Danish National Drugs Policy) "The national action plan against drug abuse from October 2010 indicates that Danish drug policy is based on four basic elements: prevention, treatment, harm reduction and control. Prohibition and control intervention will not solve the problem alone. There is also a need for targeted and persistent intervention in order to prevent, intervene, treat and reduce injury. And even more - to reduce supply of and demand for drugs.
(Punishment for Drug Offenses) "Drug-related crime is punishable under the law of psychoactive substances and Section 191 of the Danish Criminal Code. Violations of the Act on Psychoactive Substances will be punished by fine or prison for a period of no more than 2 years. In connection with sentencing, it is considered whether or not the drug is intended for own use, or if the drug has been sold or intended for selling. Also, the type and quantity of the drug is considered.